secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0001731122-22-002068
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enochian BioSciences receives second Nasdaq delisting notice over delayed 10-Q filing
--------------------------------------------------------------------------------

- Nasdaq notified Enochian on Nov 23, 2022, of non-compliance with Listing Rule 5250(c)(1) for failure to file Form 10-Q for period ended Sep 30, 2022.
- This follows a prior notice on Oct 17, 2022, for delayed Form 10-K (year ended Jun 30, 2022).
- Delay attributed to ongoing work by a third-party valuator on a company asset.
- Company must submit a compliance plan by Dec 16, 2022; if accepted, Nasdaq may grant until Apr 11, 2023 to file.
- Failure to regain compliance could lead to delisting from Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112222002068/0001731122-22-002068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112222002068/e4267_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-22-002068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer